You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)

Docket ⤷  Sign Up Date Filed 2015-08-05
Court District Court, D. Delaware Date Terminated 2018-04-24
Cause 35:0145 Assigned To Timothy Belcher Dyk
Jury Demand None Referred To
Parties ACTAVIS LABORATORIES FL, INC.; ALVOGEN PINE BROOK LLC
Patents 6,733,783; 8,114,383; 8,309,060; 8,361,499; 8,529,948; 8,551,520; 8,647,667; 8,808,740; 9,023,401; 9,056,052; 9,060,940; 9,084,816; 9,095,614; 9,095,615; 9,198,863; 9,205,056; 9,486,412; 9,486,413; 9,492,390; 9,492,391; 9,517,236; 9,545,380; 9,572,779; 9,572,804; 9,669,024; 9,675,610; 9,675,611; 9,750,703; 9,763,933; 9,775,809
Attorneys Jeffrey I.D. Lewis; Rodger Dallery Smith , II
Firms Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Alvogen Pine Brook LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-04-18 175 Hossein Omidian Regarding Invalidity of U.S. Patent Nos. 6,733,783; 8,361,499; 8,551,520; 8,647,667; 9,023,…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware External link to document
2017-04-19 177 Jacobs, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Mayersohn, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Muzzio, Ph.D. Concerning the Invalidity of U.S. Patent Nos. 8,529,948; 8,309,060; 9,084,816; 9,095,614…Ryu, Ph.D. Concerning the Indefiniteness of U.S. Patent Nos. 9,198,863 and 8,808,740 filed by Alvogen Pine…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware External link to document
2017-05-10 178 asserted claims of U.S. Patent Nos. 6,733,783 ("the '783 patent"), 8,361,499 ("the… ORDER Construing the Terms of U.S. Patent Nos. 6,733,783, 8,361,499, 8,551.520, 8,647,667, 9,023,… ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 6,733,783, 8,361,499, 8,551.520, 8,647,667, 9,023,401… patent"), 8,529,948 ("the '948 patent"), 8,808,740 ("the '740 patent"…;the '499 patent"), 8,551,520 ("the '520 patent"), 8,647,667 ("the ' External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.